ARCHIVES

Waxman’s Cancer Act Renewal Legislation: More Pluses Than Minuses; Hearing Scheduled Feb. 25

This article is from The Cancer Letter archive.

Vol. 06 No. 08 | February 22, 1980

Download PDF Visit The Full Archive

Related Articles

Report Urges Changes To Cut Activation Times For NCI Phase III Trials.

April 9, 2010

Executive Summary of Centers, SPOREs Report

February 28, 2003

In Brief: Durant To Leave Alabama, Will Become President, Chief Executive Officer At Fox Chase Cancer Center

September 17, 1982

NCI CTEP Approved Trials For the Month of December

December 27, 2013

MSKCC Asked To Repay $638,371 To NIH

December 13, 1985

Taking Tykerb With Food Increased Drug Concentration; Paper Urges More Research

July 27, 2007